Increase in Awareness Regarding Cancer Treatment Expected to Drive Global Herceptin Biosimilar Market: Ken Research

Herceptin is a specific type of monoclonal antibody, which is generally used to treat patients who are suffering from metastatic (spread) breast cancer & gastric cancers. It is also used as a part of the chemotherapy treatment for adjuvant-treatment of lymph-node positive, HER2/neu protein positive breast-cancer. Herceptin is also acknowledged as trastuzumab and primarily administered… Continue reading Increase in Awareness Regarding Cancer Treatment Expected to Drive Global Herceptin Biosimilar Market: Ken Research